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Survival from Cecal Ligation and Puncture and 
the Formation of Fibrous Adhesions in the Peritoneal 
Cavity Depend on Endogenous Tumor Necrosis Factor 
B. Echtenacher1'2, W. Falk 1' 3, D. N. Männel 1 ' 2 , and P. H. Krammer1 
The purpose of this study was to clarify the role of tumor necrosis factor (TNF) 
in the recovery from Peritonitis caused by sublethal cecal ligation and puncture 
(CLP). TNF is thought to play a beneficial role because pretreatment of mice 
with lipopolysaccharide (LPS) or TNF increased the survival rate of injected 
animals [1, 2]. To investigate the contribution of endogenous TNF to recovery 
from Peritonitis we tested the effect of a neutralizing rat anti-mouse TNF 
monoclonal antibody (Vlq) [3]. We showed that as little as 20 ^g Vlq/mouse 
effectively prevented lethal shock of the animals caused by subsequent injection 
of 400 (ig LPS, demonstrating the in vivo efficacy of the antibody. Lethal bolus 
injections of LPS or bacteria are used as sepsis models by many investigators 
[4]. In these models the potentially lethal reactions (production of large 
amounts of interleukin-1 and TNF) of the organism may develop faster than the 
regulatory inflammatory reactions (e.g., acute-phase proteins, glucocorticoids). 
Therefore, these models may represent only part of the whole inflammatory 
repertoire [5]. We preferred CLP as a sepsis model because of its slower 
development and the presence of a septic focus [6, 7]. 
For sublethal CLP 10- to 14-week-old C3H/HeN mice were anesthetized, 
and the abdominal skin was shaved. A 0.7-cm midline incision was made. The 
cecum was exteriorized and filled with feces by milking stool back from the 
ascending colon. The cecum was ligated below the ileocecal valve and punctured 
once with a 0.9 x 40 mm needle. Gentie pressure was applied on the ligated 
cecum to exteriorize a small amount of feces. The cecum was then returned to 
the peritoneal cavity and the incision closed with clamps and Histoacryl blue 
(enbucrilate) tissue glue. Mice were observed for at least 2 weeks. 
In sublethal CLP intraperitoneal injection of 0.1 mg Vlq directly and up to 
8 h after induction of experimental Peritonitis lead to death of the animals 
within 1-3 days. Only if Vlq was injected 16 h after CLP about half of the mice 
survived (Fig. 1). To correlate this result with production of endogenous TNF 
the serum of untreated CLP mice was tested for biologically active TNF. Düring 
the first 20 h no TNF was detectable.This may be explained by the assumption 
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Fig.l. Requirement of T N F for survival from C L P during the first 8 h of Peritonitis: 0 (•), 4 (A), 8 
(O), and 16 h (•) after C L P mice were injected with 100 ug monoclonal antibody V l q in 0.2 ml 
phosphate-buffered Solution. These injections were repeated 24 h after C L P 
that TNF is produced and consumed only locally at the punctured cecum. This 
was in line with findings by other investigators who also did not detect TNF 
after CLP even when they used lethal CLP or related models [8]. 
Surviving mice that were killed 2 weeks after CLP showed an encapsulated 
cecum and strong fibrous adhesions. Examination of mice that had died from 
CLP after Vlq injection showed no fibrous adhesions to the cecum 1-3 days 
after CLP. To determine any correlation between the time of declining lethality 
after Vlq injection and the occurrence of fibrous adhesions treated mice were 
killed at different times after CLP. There were no adhesions seen after 10 h. After 
15 h fibrous adhesions became visible, and after 18 h such adhesions were 
pronounced (Fig. 2). 
The lethal effect of monoclonal antibody Vlq was prevented by injection of 
recombinant mouse TNF (rmTNF). Vlq was injected immediately after CLP 
and rmTNF 1 h later. Remarkably, the same amount of rmTNF that saved CLP 
mice from lethal Vlq injection killed CLP mice if rmTNF was injected without 
previous Vlq administration. Therefore, a certain beneficial TNF concentration 
during CLP-induced Peritonitis may have to be maintained because elimination 
of endogenous TNF or additional exogenous TNF would be lethal. 
These observations may be explained by known properties of TNF. During 
the early phase of Peritonitis endogenous TNF may stimulate nonlymphoid cells 
such as granulocytes and macrophages to ingest bacteria. TNF may enhance the 
procoagulant activity of the endothelium and mesothelium [9]. In addition, 
TNF may inhibit fibrinolysis [10]. Thus, adhesions of surrounding tissue 
(omentum, intestines) to the cecum are favoured by TNF. TNF production must 
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Fig.2a-d. The cecum of C3H/HeN mice at different times after C L P and intraperitoneal injection of 
anti-TNF monoclonal antibody V l q or Phosphate-buffered Solution (PBS) only. a 18 h after C L P 
and injection of 100 ug Vlq. No adhesions at the cecum. b 42 h after C L P and injection of 100 ug 
Vlq . No adhesions at the cecum. c 18 h after C L P and injection of 100 ul PBS. Adhesions (intestine, 
Omentum) at the cecum. d 42 h after C L P and injection of 100 ug Vlq . The cecum is covered 
completely by adhesions of the intestine and Omentum 
be tightly controlled in order to avoid disseminated intravascular coagulation 
and vascular leakage. One possibility is the control of T N F secretion through 
Protease inhibitors which may prevent the cleavage of membrane T N F from the 
cell surface [11]. T N F increases interleukin-6 concentration in the blood, and 
this cytokine enhances synthesis of acute-phase proteins, some of which are 
Protease inhibitors [12]. This mechanism may also be effective in other cases in 
which serum T N F was not detectable but essential for survival because anti-
T N F antibodies caused or accelerated the death of the infected animals (e.g. 
Listeria, bacille Calmette-Guerin, Leishmania) [13, 14,15, 16]. In summary, these 
data indicate that the administration of anti-TNF antibodies in sepsis may be 
deleterious rather than beneficial. 
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